UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Allergy (Copenhagen), 2005-03, Vol.60 (3), p.309-316

2005

Volltextzugriff (PDF)

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

The New England journal of medicine, 2015-05, Vol.372 (21), p.1987-1995

2015

Volltextzugriff (PDF)

Minimal Clinically Important Differences in Pharmacological Trials

American journal of respiratory and critical care medicine, 2014-02, Vol.189 (3), p.250-255

2014

Volltextzugriff (PDF)

How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

American journal of respiratory and critical care medicine, 2017-07, Vol.196 (2), p.139-149

2017

Volltextzugriff (PDF)

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease

Tuberculosis and respiratory diseases, 2016-10, Vol.79 (4), p.241

Beeh, Kai M.

2016

Volltextzugriff (PDF)

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.2545-2558

2017

Volltextzugriff (PDF)

Bronchodilator effects of indacaterol and formoterol in patients with COPD

Pulmonary pharmacology & therapeutics, 2009-12, Vol.22 (6), p.492-496

2009

Volltextzugriff (PDF)

Erectile dysfunction in patients with first‐episode psychosis

Andrologia, 2020-12, Vol.52 (11), p.e13793-n/a

2020

Volltextzugriff (PDF)

Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial

Chest, 2013-03, Vol.143 (3), p.711-719

2013

Volltextzugriff (PDF)

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

International journal of chronic obstructive pulmonary disease, 2012-01, Vol.7 (default), p.503-513

2012

Volltextzugriff (PDF)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

International journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.2745-2755

2022

Volltextzugriff (PDF)

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects

Respiratory medicine, 2003-06, Vol.97 (6), p.634-639

2003

Volltextzugriff (PDF)

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

Thorax, 2003-03, Vol.58 (3), p.211-216

2003

Volltextzugriff (PDF)

The environmental impact of inhaled therapy: making informed treatment choices

The European respiratory journal, 2022-07, Vol.60 (1), p.2102106

2022

Volltextzugriff (PDF)

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

The New England journal of medicine, 2011-03, Vol.364 (12), p.1093-1103

2011

Volltextzugriff (PDF)

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals

The European respiratory journal, 2000-10, Vol.16 (4), p.609-614

2000

Volltextzugriff (PDF)

Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis

The European respiratory journal, 2002-06, Vol.19 (6), p.1119-1123

2002

Volltextzugriff (PDF)

Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.1701-1711

2018

Volltextzugriff (PDF)

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.1425-1434

2016

Volltextzugriff (PDF)

A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5

Clinical and experimental allergy, 2003-04, Vol.33 (4), p.475-482

2003

Volltextzugriff (PDF)

Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?

Clinical and experimental allergy, 2006-02, Vol.36 (2), p.142-157

2006

Volltextzugriff (PDF)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial

Respiratory research, 2013-10, Vol.14 (1), p.116-116, Article 116

2013

Volltextzugriff (PDF)

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy

Terapevtic̆eskii arhiv, 2020-01, Vol.92 (1), p.89-95

2020

Volltextzugriff (PDF)

Antiinflammatory properties of ambroxol

European journal of medical research, 2008-12, Vol.13 (12), p.557-562

2008

Volltextzugriff (PDF)

The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease

Advances in therapy, 2010-03, Vol.27 (3), p.150-159

2010

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Humans
(78)
Life Sciences & Biomedicine
(75)
Male
(53)
Female
(49)
Respiratory System
(47)
Middle Aged
(46)
Adult
(40)
Biological And Medical Sciences
(40)
Medical Sciences
(38)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(33)
Aged
(31)
Copd
(28)
Chronic Obstructive Pulmonary Disease
(26)
Double-Blind Method
(24)
Treatment Outcome
(24)
Pneumology
(23)
Asthma
(21)
Administration, Inhalation
(19)
Bronchodilator Agents - Therapeutic Use
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

Minimal Clinically Important Differences in Pharmacological Trials

How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

Bronchodilator effects of indacaterol and formoterol in patients with COPD

Erectile dysfunction in patients with first‐episode psychosis

Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

The environmental impact of inhaled therapy: making informed treatment choices

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals

Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis

Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5

Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy

Antiinflammatory properties of ambroxol

The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease

Suchergebnisse filtern